Biotech Startups
9,920 companies tagged Biotech, with their investors and founders.
CoreMap develops medical technology that lets physicians visualize atrial fibrillation (AF), an irregular heart arrhythmia, to inform better treatment options for patients. It targets cardiac electrophysiology and diagnostics.
2 investors
CorrectSequence Therapeutics develops base-editing gene therapies using its proprietary transformer Base Editor (tBE) platform to treat genetic diseases, rare diseases, and common conditions including inherited disorders, metabolic diseases, cardiovascular diseases, and cancers. The company has advanced multiple pipeline candidates into clinical and investigational stages, including programs for Ξ²-thalassemia and sickle cell disease.
2 investors
CorWave produces a ventricular assist pump for advanced heart failure patients, delivering pulsatile flow to provide mechanical cardiac support for transplant candidates, non-transplant-eligible patients, and recovery cases.
2 investors
Cosaic develops ingredient solutions to create resilient food systems that align with consumer preferences. The company focuses on sustainability and industry resilience in food production.
2 investors
Cosomil develops single-molecule enzyme activity measurement technology for early disease diagnosis and drug development support in healthcare. The company serves medical research institutions, pharmaceutical manufacturers, and diagnostic laboratories in Japan.
2 investors
Cosyne operates a platform that combines biology, computation, and finance, using a hub-and-spoke model to spin out assets into subsidiaries as a distributed portfolio approach. The company operates laboratories focused on computational and experimental work across London, Cambridge, and New York.
2 investors
Cotton Mouton Diagnostics operates a UKAS-accredited laboratory offering endotoxin testing services for liquid pharmaceutical products, including method development, validation, and low endotoxin recovery studies. It also produces the Ξ±BET System, an in-house testing platform combining FUJIFILM Wako's licensed LAL reagent with its own magneto-optical technology for pharmaceutical and diagnostics customers.
2 investors
Coultreon is a drug discovery and development company that advances small and large molecule therapeutic programmes across various disease areas, combining disease biology expertise with technology platforms.
2 investors
Cove builds brain data analytics tools that combine data engineering and neuroscience to support patient care. The company is developed by a team of physicians, neuroscientists, and software engineers.
2 investors
Craif develops biomarker analysis and AI-driven diagnostic solutions to enable early disease detection and personalized treatment through non-invasive testing of body fluids.
2 investors
CREATE Medicines is a clinical-stage biotech company that develops in vivo mRNA immune cell programming therapies. The company focuses on RNA therapeutics and immune engineering for cancer, autoimmune disease, and transplant rejection applications.
2 investors
Lang Lai Technology (ζζ₯η§ζ) is a clinical-stage drug discovery company that runs an end-to-end new-drug R&D process spanning proof of concept, candidate compound screening, preclinical druggability development, and clinical research, pursuing both pipeline development and platform building. It operates R&D, translational medicine, and clinical centers across China and a business-development/FDA-filing center in the United States.
2 investors
Creyon develops aptamer-delivered oligonucleotide therapeutics for targeted cell-specific delivery, including small interfering RNA and antisense oligonucleotides. The company's platform addresses limitations in tissue penetration and immunogenicity for central nervous system and other tissue-targeted applications.
2 investors
CRISPR Therapeutics is a biotechnology company developing gene-based medicines using CRISPR/Cas9 gene-editing technology. It is led by a management team, board of directors, and scientific founders from the biotech and pharmaceutical industries.
2 investors
2 investors
Cristal Therapeutics develops therapeutics in the life sciences sector. The page does not provide sufficient details about specific products, customer segments, or market focus to construct a fuller description.
2 investors
Crossbow Therapeutics develops TCR-mimetic antibody therapies designed to target cancer antigens by mimicking T-cell receptors, with a focus on treating solid tumors and hematologic malignancies. The company creates next-generation T-cell engagers incorporating its proprietary T-Boltβ’ molecules to enhance therapeutic potency and manufacturability.
2 investors
CrossBridge Bio, launched in 2023, develops next-generation antibody-drug conjugates (ADCs) to address a range of cancer indications. The company originated from ADC technology developed at the University of Texas Health Science Center at Houston.
2 investors
Cryosa develops an incisionless medical treatment that uses controlled cooling to reduce tissue and open airways. The company serves patients requiring airway management procedures.
2 investors
CryoVeritas makes user-activated temperature indicators that integrate both time and temperature to confirm the integrity of vaccines and biospecimens exposed to heat during cold-chain storage down to β200 Β°C. Its "Pinktail" indicators are tunable from 5 minutes to 48+ hours and serve biorepositories, IVF/reproductive tissue banks, cell therapy, mRNA vaccine, blood banking, and forensic storage applications.
2 investors
CSafe develops temperature-controlled shipping solutions for the pharmaceutical and life sciences cold chain, including active and passive air cargo containers, parcel shippers, and cryogenic dewars for cell and gene therapies. It serves biopharma logistics worldwide with a network of service centers, manufacturing facilities, and real-time tracking technology.
2 investors
Cullinan Therapeutics is a clinical-stage biotech company developing therapeutic molecules for autoimmune diseases and cancer, with expertise in immune modulation. The company focuses on first- or best-in-class treatments to improve outcomes for patients managing these conditions.
2 investors
Cultivated develops Cosaic Neo, a multipurpose food ingredient that combines texture, nutrition, and clean-label properties for beverage and food manufacturers. The product addresses the compromise between taste, nutritional performance, and ingredient transparency in food formulation.
2 investors
NeuLogiq is a research platform for clinical trials that integrates tablet-based cognitive assessments, EEG monitoring, and real-world behavioral data to measure brain function changes. The platform serves biopharma sponsors and clinical research sites conducting central nervous system studies across phases 0-3.
2 investors